Marina Protopopova
Plus aucun poste en cours
Profil
Marina Protopopova worked as Vice President-Drug Discovery at Sequella, Inc., Principal at National Institutes of Health, and Principal at Regis Technologies, Inc. She graduated from Moscow State University with a graduate degree and received a doctorate from the Russian Academy of Sciences.
Anciens postes connus de Marina Protopopova
| Sociétés | Poste | Fin |
|---|---|---|
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Regis Technologies, Inc.
 Regis Technologies, Inc. Chemicals: SpecialtyProcess Industries Regis Technologies, Inc. is a private company that offers high-quality GC derivatization reagents for gas chromatography separations. Regis Technologies is based in Morton Grove, IL and offers a range of services including solid-state chemistry, impurity services, custom API manufacturing, and more. The company provides process and analytical development of small molecule APIs for pharma companies, as well as chromatography consumables. The company partners with pharma and biotech companies to expedite small molecule drug candidates to market with CGMP manufacturing services and products. The company also provides technical and customer support, safety data sheets, certificates of analysis, and video/literature libraries. The company has a CGMP facility with a range of equipment and capabilities to manufacture lead molecules, and they offer chromatography products including chiral and achiral columns for SFC, RPLC, and specialty reagents. Quality assurance ensures the CGMP compliance of products, tracking all CGMP production from raw material receipt to final product release. | Corporate Officer/Principal | - |
Sequella, Inc.
 Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Directeur Technique/Scientifique/R&D | - |
Formation de Marina Protopopova
| Russian Academy of Sciences | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Health Technology |
| Moscow State University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Regis Technologies, Inc.
Regis Technologies, Inc. Chemicals: SpecialtyProcess Industries Regis Technologies, Inc. is a private company that offers high-quality GC derivatization reagents for gas chromatography separations. Regis Technologies is based in Morton Grove, IL and offers a range of services including solid-state chemistry, impurity services, custom API manufacturing, and more. The company provides process and analytical development of small molecule APIs for pharma companies, as well as chromatography consumables. The company partners with pharma and biotech companies to expedite small molecule drug candidates to market with CGMP manufacturing services and products. The company also provides technical and customer support, safety data sheets, certificates of analysis, and video/literature libraries. The company has a CGMP facility with a range of equipment and capabilities to manufacture lead molecules, and they offer chromatography products including chiral and achiral columns for SFC, RPLC, and specialty reagents. Quality assurance ensures the CGMP compliance of products, tracking all CGMP production from raw material receipt to final product release. | Process Industries |
